Move Over, Marijuana: Psychedelic Drugs Could Be the Next Big Thing
By Aaron Kesel Several companies that are developing medical treatments from psychedelic drugs like LSD, ketamine, and psilocybin—the active ingredient in magic mushrooms—are getting ready to list on Canadian stock exchanges. One of those companies, Mind Medicine Inc., has been involved in clinical trials of…